Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

被引:330
作者
Kato, M. [1 ,2 ]
Serretti, A. [1 ]
机构
[1] Univ Bologna, Inst Psychiat, I-40123 Bologna, Italy
[2] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan
关键词
depression; meta-analysis; polymorphism; treatment response; side effects; pharmacogenetics; SEROTONIN TRANSPORTER GENE; TRYPTOPHAN-HYDROXYLASE GENE; PROTEIN BETA-3 SUBUNIT; 5-HT2A RECEPTOR GENE; TERM TREATMENT RESPONSE; CONVERTING-ENZYME GENE; MONOAMINE-OXIDASE-A; FUNCTIONAL PROMOTER POLYMORPHISM; MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR GENE;
D O I
10.1038/mp.2008.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This systematic review summarizes pharmacogenetic studies on antidepressant response and side effects. Out of the 17 genes we reviewed, 8 genes were entered into the meta-analysis (SLC6A4, HTR1A, HTR2A, TPH1, gene encoding the beta-3 subunit, brain-derived neurotrophic factor (BDNF), HTR3A and HTR3B). TPH1 218C/C genotype (7 studies, 754 subjects) was significantly associated with a better response (odds ratio, OR = 1.62; P = 0.005) with no heterogeneity between ethnicities. A better response was also observed in subjects with the Met variant within the BDNF 66Val/Met polymorphism (4 studies, 490 subjects; OR = 1.63, P = 0.02). Variable number of tandem repeats polymorphism within intron 2 (STin2) 12/12 genotype showed a trend toward a better response in Asians (STin2: 5 studies, 686 subjects; OR = 3.89, P = 0.03). As for side effects, pooled ORs of serotonin transporter gene promoter polymorphism (5-HTTLPR) I (9 studies, 2642 subjects) and HTR2A - 1438G/G (7 studies, 801 subjects) were associated with a significant risk modulation (OR = 0.64, P = 0.0005) and (OR = 1.91, P = 0.0006), respectively. Interestingly, this significance became more robust when analyzed with side effect induced by selective serotonin reuptake inhibitors only (5-HTTLPR: P = 0.0001, HTR2A: P < 0.0001). No significant result could be observed for the other variants. These results were not corrected for multiple testing in each variant, phenotype and subcategory. This would have required a Bonferroni significance level of P < 0.0023. Although some heterogeneity was present across studies, our finding suggests that 5-HTTLPR, STin2, HTR1A, HTR2A, TPH1 and BDNF may modulate antidepressant response. Molecular Psychiatry (2010) 15, 473-500; doi:10.1038/mp.2008.116; published online 4 November 2008
引用
收藏
页码:473 / 500
页数:28
相关论文
共 185 条
[11]   Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes:: a meta-analysis of pharmacogenetic interactions [J].
Bakker, P. R. ;
van Harten, P. N. ;
van Os, J. .
MOLECULAR PSYCHIATRY, 2008, 13 (05) :544-556
[12]   Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement [J].
Baum, A. E. ;
Hamshere, M. ;
Green, E. ;
Cichon, S. ;
Rietschel, M. ;
Noethen, M. M. ;
Craddock, N. ;
McMahon, F. J. .
MOLECULAR PSYCHIATRY, 2008, 13 (05) :466-467
[13]   Serotonin receptor 1A-1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression? [J].
Baune, B. T. ;
Hohoff, C. ;
Roehrs, T. ;
Deckert, J. ;
Arolt, V. ;
Domschke, K. .
NEUROSCIENCE LETTERS, 2008, 436 (02) :111-115
[14]  
Belelli D, 1995, MOL PHARMACOL, V48, P1054
[15]   Schizophrenia genetics: dysbindin under the microscope [J].
Benson, MA ;
Sillitoe, RV ;
Blake, DJ .
TRENDS IN NEUROSCIENCES, 2004, 27 (09) :516-519
[16]   Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database [J].
Bertram, Lars ;
McQueen, Matthew B. ;
Mullin, Kristina ;
Blacker, Deborah ;
Tanzi, Rudolph E. .
NATURE GENETICS, 2007, 39 (01) :17-23
[17]   Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment [J].
Binder, EB ;
Salyakina, D ;
Lichtner, P ;
Wochnik, GM ;
Ising, M ;
Pütz, B ;
Papiol, S ;
Seaman, S ;
Lucae, S ;
Kohli, MA ;
Nickel, T ;
Künzel, HE ;
Fuchs, B ;
Majer, M ;
Pfennig, A ;
Kern, N ;
Brunner, J ;
Modell, S ;
Baghai, T ;
Deiml, T ;
Zill, P ;
Bondy, B ;
Rupprecht, R ;
Messer, T ;
Köhnlein, O ;
Dabitz, H ;
Brückl, T ;
Müller, N ;
Pfister, H ;
Lieb, R ;
Mueller, JC ;
Lohmussaar, E ;
Strom, TM ;
Bettecken, T ;
Meitinger, T ;
Uhr, M ;
Rein, T ;
Holsboer, F ;
Muller-Myhsok, B .
NATURE GENETICS, 2004, 36 (12) :1319-1325
[18]   Serotonin 2A-1438 G/A and G-protein beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects [J].
Bishop, Jeffrey R. ;
Moline, Jessica ;
Ellingrod, Vicki L. ;
Schultz, Susan K. ;
Clayton, Anita H. .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (10) :2281-2288
[19]  
Bozina N., 2007, WORLD J BIOL PSYCHIA, P1
[20]   The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain [J].
Bray, NJ ;
Buckland, PR ;
Hall, H ;
Owen, MJ ;
O'Donovan, MC .
MOLECULAR PSYCHIATRY, 2004, 9 (01) :109-114